NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- Xi urges deepening reform, opening-up during Guangdong inspection tour
- Xi attends carrier's commissioning
- Xi inspects Meizhou in South China's Guangdong
- Senior Xi'an official facing probe by China's anti-corruption watchdogs
- Philippines risks creating trouble for itself: China's defense ministry
- Newborn with congenital heart disease receives life-saving surgery in Yunnan
